Hasil Pencarian
	Ditemukan 848 dokumen dengan kata kunci 7618 Simpan CSV  Outcome of BRCA1- compared with BRCA2-associated ovarian cancer: a nationwide study in the Netherlands No. Panggil: Annals of Oncology; Volume 24, No.8, August, 2013,p.2036-2042 | Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  :: Promoter methylation of BRCA1 in triple-negative breast cancer predicts sensitivity to adjuvant chemotherapy No. Panggil: Annals of Oncology; Volume 24, No.6, June, 2013, p.1498-1505 | Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  :: Conservative management of early-stage epithelial ovarian cancer: results of a large retrospective series No. Panggil: Annals of Oncology; Volume 24: No.1 Januari 2013, p.138–144 | Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  :: A randomized phase II study evaluating the combination of carboplatin-based chemotherapy with pertuzumab versus carboplatin-based therapy alone in patients with relapsed, platinum-sensitive ovarian cancer No. Panggil: Annals of Oncology; Volume 24, No.1, January 2013, p.145-152 | Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  :: Conservative management of early-stage epithelial ovarian cancer: results of a large retrospective series No. Panggil: Annals of Oncology; Volume 24, No.1, January 2013, p.138-144 | Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  :: Long-Term Ovarian Cancer Survival Associated With Mutation in BRCA1 or BRCA2 No. Panggil: JNCI Journal of the National Cancer Institute; Volume 105, No.2, 16 January, 2013: p.141-148 | Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  :: miR-9 Regulation of BRCA1 and Ovarian Cancer Sensitivity to Cisplatin and PARP Inhibition No. Panggil: JNCI Journal of the National Cancer Institute; Volume 105, No.22, 20 November 2013: p.1750-1758 | Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  :: A multicenter, randomized trial of flat dosing versus intrapatient dose escalation of single-agent carboplatin as first-line chemotherapy for advanced ovarian cancer: an SGCTG (SCOTROC 4) and ANZGOG study on behalf of GCIG No. Panggil: Annals of Oncology; Volume 24, No.3, Maret, 2013, p.679-687 | Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  :: The Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial and Its Associated Research Resource No. Panggil: JNCI Journal of the National Cancer Institute; Volume 105, No.22, 20 November 2013: p.1684-1693 | Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  :: Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): The NORDIC NEC study No. Panggil: Annals of Oncology; Volume 24: No.1 Januari 2013, p.152-160 | Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  :: Prev   1 2 3 4 5 6 7 8 9 10  Next